We recently demonstrated that LGR5-CAR-T cells exhibited anti-tumor activities against ovarian cancer cell lines, primary HGSOC cells [133], and CRC cell lines in vitro and in vivo [141]. This evidence concerns the gene LGR5 and neoplasm.